Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Organisation › Details

Selexis S.A.

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. With more than 100 partners worldwide, 95 drug products in clinical development and three commercial products utilizing Selexis-generated cell lines, the Company has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research. *

 

Period Start 2001-01-01 established
  Group JSR Corporation (Group)
Products Industry SUREtechnology Platform™ (Selexis)
  Industry 2 CHO cell line
Persons Person Fisch, Igor (Selexis 201008 CEO + co-founder)
  Person 2 Onakunle, Yemi (JSR Corp 202001– promoted to CBO of Selexis joined 2012 before Diosynth RTP Inc + Lonza)
     
Region Region Plan-les-Ouates GE
  Country Switzerland
  Street 18 Chemin des Aulx
  City 1228 Plan-les-Ouates GE
  Tel +41-22-308-9360
    Address record changed: 2018-07-24
     
Basic data Employees B: 11 to 50 (2017-05-11)
     
    * Document for �About Section�: Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva.
     
   
Record changed: 2020-01-19

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for JSR Corporation (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top